Clinical Trials

Showing trials with last updates posted in 2026.

NCT06772623 | RECRUITING | PHASE1/PHASE2
252 participants
NCT06694454 | SUSPENDED | PHASE1/PHASE2
60 participants

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2026-09-09
Completion:
2031-12-31
Conditions
  • Non-small Cell Lung Cancer (NSCLC)
  • Carcinoma, Non-Small Cell Lung
  • Non-Small Cell Lung Carcinoma
  • Non Small Cell Lung Cancer
  • Non Small Cell Lung Carcinoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page